134 results
Page 2 of 7
8-K
EX-99.2
deh6d
21 Jun 23
Regulation FD Disclosure
8:50am
8-K
2wywadudl
21 Jun 23
Regulation FD Disclosure
8:50am
8-K
o4g68e 551diy7lxpy
14 Jun 23
Regulation FD Disclosure
8:53am
8-K
8uz05livk8msx2bmwqy7
12 May 23
Regulation FD Disclosure
5:17pm
8-K
EX-99.1
kz5skt8
28 Apr 23
SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications
9:04am
8-K
60y ocka86wjm78bs4e
28 Apr 23
SAB Biotherapeutics Announces Positive Results from Phase 3 Trial of SAB-185 in Patients with COVID-19 at High-Risk for Severe Complications
9:04am
8-K
EX-99.1
ephkdh2q6bail r10
19 Apr 23
SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy
5:05pm
8-K
ol7vi
19 Apr 23
SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy
5:05pm
8-K
EX-99.1
0wcagqeav12
14 Apr 23
Regulation FD Disclosure
8:58am
8-K
b26a259wjmdk8z
14 Apr 23
Regulation FD Disclosure
8:58am
8-K
EX-99.1
917gqgjg9l34i0cypeyd
4 Apr 23
SAB Biotherapeutics Announces Appointment of Erick Lucera, CFA to Board of Directors
9:34am
8-K
me43mmfh8vo6
31 Mar 23
SAB Biotherapeutics Provides Company Update for Full Year 2022
5:12pm